Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2004
03/24/2004EP1399549A1 Anticomplement polypeptide from salivary glands of the tick ixodes ricinus
03/24/2004EP1399548A2 Conjugate of a transport protein and a protein for modulation of notch signalling
03/24/2004EP1399547A1 METHODS AND COMPOSITIONS COMPRISING i RENILLA /i GFP
03/24/2004EP1399546A2 Recombination method
03/24/2004EP1399545A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method
03/24/2004EP1399543A2 Endo-beta-1,4-glucanase
03/24/2004EP1399541A2 N4 virion single-stranded dna dependent rna polymerase
03/24/2004EP1399538A2 Engineering intracellular sialylation pathways
03/24/2004EP1399537A2 Therapeutic polypeptides, nucleic acids encoding same and methods of use
03/24/2004EP1399484A2 Dual-specific ligand and its use
03/24/2004EP1399483A2 Antibodies to insulin-like growth factor i receptor
03/24/2004EP1399481A1 Recombinant antibodies against infectious bursal disease virus (ibdv)
03/24/2004EP1399480A2 Multimers of class i major histocompatibility complexes containing modified beta2-microglobulin proteins
03/24/2004EP1399479A2 Cation conducting gaba a receptors and their use
03/24/2004EP1399478A2 Cancer-testis antigens
03/24/2004EP1399475A2 Mutants of igf binding proteins and methods of production of antagonists thereof
03/24/2004EP1399474A2 Secreted proteins and their use
03/24/2004EP1399473A2 Insecticidal proteins and synergistic combinations thereof
03/24/2004EP1399472A2 Soluble heterodimeric cytokine receptor
03/24/2004EP1399462A1 Combined approach to treatment of cancer using a c-myc antisense oligomer
03/24/2004EP1399461A2 Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1f7
03/24/2004EP1399460A2 Breast cancer-associated genes and uses thereof
03/24/2004EP1399459A1 Reagent for the isolation of rna
03/24/2004EP1399457A1 Processes of purifying oligonucleotides
03/24/2004EP1399215A2 Tissue-specific endothelial membrane proteins
03/24/2004EP1399189A1 Compositions and methods for enhancing nucleic acid transfer into cells
03/24/2004EP1399183A2 Chimeric alphavirus replicon particles
03/24/2004EP1399168A1 Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours
03/24/2004EP1399162A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
03/24/2004EP1399023A2 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
03/24/2004EP1399016A2 Method for generating diversity
03/24/2004EP1399012A2 Compositions and methods for the production of betaine lipids
03/24/2004EP1292606A4 Positively-charged peptide nucleic acid analogs with improved properties
03/24/2004EP1250463A4 Sensitive, multiplexed diagnostic assays for protein analysis
03/24/2004EP1231934B1 Methods of inhibiting atrophy or promoting hypertrophy
03/24/2004EP1218542B1 Methods and compositions for linear isothermal amplification of polynucleotide sequences
03/24/2004EP1121455A4 Zinc finger peptide cleavage of nucleic acids
03/24/2004EP0969083B1 Dna capillary
03/24/2004EP0900002B1 H2-m modified transgenic animals
03/24/2004EP0871736B1 PESTICIDAL COMPOSITION COMPRISING CryIF CHIMERIC AND CryIA(c) CHIMERIC BACILLUS THURINGIENSIS DELTA-ENDOTOXIN
03/24/2004EP0869970B1 Endothelial cell proliferation inhibitor and its use
03/24/2004EP0850319B1 Method for modulating cell apoptosis
03/24/2004EP0796277B1 Fusion junction type iii mutant egf receptor peptide tumour vaccine
03/24/2004EP0795015B1 Plasmids suitable for il-2 expression
03/24/2004EP0777494B1 Human chemokine polypeptides
03/24/2004EP0726953B1 Human kunitz-type protease inhibitors
03/24/2004EP0702729B1 Chemical process for amplifying and detecting nucleic acid sequences
03/24/2004EP0625212B1 Methods of detecting alzheimer's disease
03/24/2004CN1484764A Method of reusing DNA-immobilization substate
03/24/2004CN1484710A Bio-chip photoluminescent method for identifying biological material and apparatuses for use with such methods and bio-chips
03/24/2004CN1484709A Method and compositions for isolating metastatic cancer cells and use in measuring metastatic potential of a cancer thereof
03/24/2004CN1484708A Ascorbic acid production from yeasts
03/24/2004CN1484707A Methods of modifying eukaryotic cells
03/24/2004CN1484706A Photochemical internalization for virus-mediated molecule delivery into the cyosol
03/24/2004CN1484705A Dan encoding a plant lipase transgenic plants and a method for controlling senescence in plants
03/24/2004CN1484704A Deoxymugineic acid synthase and gene thereof
03/24/2004CN1484703A Novel glucuse dehydrogenase and process for producing the dehydrogenase
03/24/2004CN1484702A Novel bacillus thuringiensis insecticidal proteins
03/24/2004CN1484701A Polyp eptide having a isomal tosylglucosaccharide synthase activity
03/24/2004CN1484700A Aop beta gene protein homologs fragments and thereof and their use for cell surface display
03/24/2004CN1484699A Novel mutant allergens
03/24/2004CN1484698A Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains
03/24/2004CN1484696A Putrescine-N-Methyl transferase promoter
03/24/2004CN1484694A Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
03/24/2004CN1484692A Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing canceg said protooncogene
03/24/2004CN1484652A Antibodies to human IL-1 beta
03/24/2004CN1484651A Production of recombinant BMP-2
03/24/2004CN1484650A Urocortin proteins and uses thereof
03/24/2004CN1484497A Protein hydrol ysater enriched in peptides having a carboxy termina proline residue
03/24/2004CN1483831A Process for obtaining insulin and insulin derivatives having correctly bonded crystine bridges
03/24/2004CN1483823A Engineering systhesized gene cry LC of pests-killing crytal protein of Bacillus thuringiensis Berliner
03/24/2004CN1483822A Promotor for controlling plant root system development and use thereof
03/24/2004CN1483821A Gene for controlling plant root system development and its coding products and use
03/24/2004CN1483820A Carcinoma of esophagus related gene-2 and use of coding protein thereof
03/24/2004CN1483819A Method for controlling plant flower bud areloe position and use thereof
03/24/2004CN1483816A Colibacillns strain for recombination producing lectin of snowdrop and method thereof
03/24/2004CN1483741A Novel human protein with cancer-suppressing function and coding sequence thereof
03/24/2004CN1483740A Novel human protein with function for suppressing cancer and coding sequence thereof
03/24/2004CN1483739A Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof
03/24/2004CN1483738A Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof
03/24/2004CN1483735A Mangrove betaine aldenyde dehydrogenase gene and method for raising plant salt-resisting property
03/24/2004CN1483662A Method for preparing nanowive crossbar structure and use of structure prepared by said method
03/24/2004CN1483413A Medicinal composition for treationg virus infention of rlavivirus family, set group and packaged products
03/24/2004CN1142999C Solid support with attached molecules
03/24/2004CN1142997C Process for producing D-pantoic acid and D-pantothenic acid or salts thereof
03/24/2004CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/24/2004CN1142941C Cells bearing CD4 decoy receptors and related molecules and methods
03/24/2004CN1142821C Self-dadressable self-assembling microelectronic system and devices for molecular biological analysis
03/23/2004US6710229 Plants having drought, cold, and/or salt tolerance
03/23/2004US6710228 Heterologous sequence encoding a pesticidal lectin
03/23/2004US6710227 Cyclin-dependent kinase inhibitors and uses thereof
03/23/2004US6710189 Genetically engineered polyketide synthase for use in the generation of preferential antibiotics
03/23/2004US6710174 For therapy of cancer, disease or condition involves angiogenesis, and rheumatoid arthritis
03/23/2004US6710172 Tumor antigens and CTL clones isolated by a novel procedure
03/23/2004US6710171 Isolated dna encoding protein having specified amino acid sequence; treating or preventing arteriosclerosis and restenosis after treatment of artery occlusion
03/23/2004US6710165 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects
03/23/2004US6710163 Compounds that bind single-stranded dna and rna strands to form stable hybrids; bind complementary single-stranded dna and rna strands more strongly than corresponding dna
03/23/2004US6710037 Method of treating androgen-dependent disorders
03/23/2004US6710035 Interstitial introduction of an isolated polynucleotide into a tissue of the vertebrate where polynucleotide is taken up by the cells of the tissue and exerts a therapeutic effect on the vertebrate to provide immune response
03/23/2004US6710031 Protein having antithrombotic activity and method for producing the same